← All indications
Hepatitis A
INFLAMMATION of the LIVER in humans caused by a member of the HEPATOVIRUS genus, HUMAN HEPATITIS A VIRUS. It can be transmitted through fecal contamination of food or water.
Drugs by status
Approved for this indication (5)
Phase 4 trials (13)
- epaxal
- pneumococcal 13-valent conjugate vaccine
- hepatitis b vaccine (recombinant)
- typhoid vi polysaccharide vaccine
- attenuated measles vaccine - Edmonston strain
- inactivated influenza vaccine
- measles, mumps, rubella, varicella vaccine
- measles, mumps, and rubella vaccine
- inactivated varicella vaccine
- typhoid vaccine, live oral
- Monovalent group A meningococcal vaccine
- Inactivated polio virus - Enhanced
- hepa-l
Phase 3 trials (10)
- aldesleukin
- lactose
- inactivated japanese encephalitis vaccine
- hepatyrix
- Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine
- live attenuated varicella vaccine
- undecavalent pneumococcal-protein d conjugate vaccine
- silymarin
- haemophilus influenzae type b conjugate vaccine
- mevac-a vaccine
Phase 2 trials (2)
Other trials (1)
Organizations
Organization Involved with Phase 4 Indications (384)
- RWTH Aachen University
- Federal University of Goias
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- University of Kinshasa
- University of Helsinki
- University of South Florida
- Pusan National University
- GlaxoSmithKline
- Iranian Blood Transfusion Research Center
- International Society for Infectious Diseases
- Harvard University
- Ain Shams University
- University of South Carolina
- Oswaldo Cruz Foundation
- University of Nebraska
- First People's Hospital, Shunde China
- Hebei Medical University
- New Discovery LLC
- Tianjin University
- Tai'an Central Hospital
- Schering-Plough
- Shenzhen Kangtai Biological Products Co., LTD
- The Geneva Foundation
- Cornell University
- C&R Research, Inc.
- University of Miami
- Government of China
- Chong Kun Dang Pharmaceutical
- Yeungnam University
- University of Oxford
- +354 more
Organization Involved with Phase 3 Indications (137)
- Hopital Principal de Dakar Senegal
- Mahidol University
- Medipoint Hospitals Pvt. Ltd.
- Aalborg University
- Aclin Laboratories, Chile
- Tel Aviv University
- University of Lille
- National Center for Research Resources (NCRR)
- Jiangsu Hansoh Pharmaceutical Co., Ltd.
- Moscow State University
- Siriraj Hospital
- Southern California Institute for Research and Education
- The Egyptian Company for Blood Transfusion Services
- M V Hospital & Research Center, Lucknow
- West China Hospital
- Bharti Hospital
- Iran Hepatitis Network
- RojanPharma Pharmaceutical Company
- Institute of Liver and Biliary Sciences, India
- Tibotec
- Xiamen Amoytop Biotech Co., Ltd.
- NUCLIMED
- TaiwanJ Pharmaceuticals Co., Ltd
- University of Louisville
- BioGeneric Pharma
- Utrecht University
- Clinical Research Organization, Dhaka, Bangladesh
- Pharmasset
- Jilin University
- Medical College of Virginia
- +107 more
Organization Involved with Phase 2 Indications (196)
- Ascletis Pharmaceuticals Co., Ltd.
- University of Lausanne
- Los Angeles Biomedical Research Institute
- Vaxine Pty Ltd
- PharmaKing
- Sunshine Lake Pharma Co., Ltd.
- University of Minnesota
- Alios BioPharma
- Guangzhou Baidi Biotechnology Co., Ltd
- Tokyo Metropolitan Komagome Hospital
- Assembly Biosciences
- Shanghai HEP Pharmaceatical Co., Ltd.
- Florida Center for Gastroenterology
- CTI BioPharma
- EFiS
- Immune Tolerance Network
- University of Basel
- Digna Biotech S.L.
- University of Pisa
- Moscow Regional Resarch adn Clinical Institute
- Universidad Complutense de Madrid
- University of Auckland
- PPD
- Can-Fite BioPharma
- University of Guadalajara
- Bnai Zion Medical Center
- Nashville Medical Research Institute
- Centocor
- Beni Suef University
- Australian Respiratory and Sleep Medicine Institute
- +166 more
Organization Involved with Phase 1 Indications (54)
- Hepion Pharmaceuticals
- Cathay General Hospital
- Quest Clinical Research
- Genexine, Inc.
- National Institute for Health Research, United Kingdom
- University of Edinburgh
- PharmaEssentia Corp.
- Aceragen, Inc/
- GeneOne Life Science
- Maharaj Nakorn Chiang Mai Hospital
- Alamo Medical Research
- Avid Bioservices
- Sclnow Biotechnology Co., Ltd.
- Wycombe Hospital, High Wycombe, Buckinghamshire
- Nucorion Pharmaceuticals, Inc.
- City University of Hong Kong
- Synteract, Inc.
- University of Zurich
- European Commission
- Enanta Pharmaceuticals
- University Health Network, Toronto
- Epoch Biosciences
- Medical University of Warsaw
- Temple University
- Hengrui Therapeutics, Inc.
- University of Birmingham
- Padjadjaran University
- Government of Brazil
- Microbio Co Ltd
- iTherX Pharmaceuticals Inc.
- +24 more
Organization Involved with Other Experimental Indications (42)
- Vietnamese Military
- Sanjay Gandhi Postgraduate Institute of Medical Sciences
- Government of Kazakhstan
- Changhai Hospital
- Saint Luke's Health System
- Medical College of Wisconsin
- State Department of Health of Rio Grande do Sul
- Bar Ilan University
- Medical University of Graz
- Parexel
- New Jeddah Clinic Hospital
- Hospital General Dr. Manuel Gea Gonzalez
- Triệu, Nguyễn Thị, M.D.
- Reliant Pharmaceuticals
- Charles Drew University
- Ram Manohar Lohia Insitute of Medical Sciences
- University of Missouri, Kansas City
- Chulalongkorn University
- Universidad Autonoma del Estado de Mexico
- Zhengzhou University
- Indian Council of Medical Research
- American College of Gastroenterology
- Government of Punjab, India
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- Eurasia Invest Ltd., Kazakhstan
- Organic India
- West Virginia University
- Hillel Yaffe Medical Center
- Lady Hardinge Medical College
- Sao Paulo State University
- +12 more